Fujiki Y, Tsuneoka M, Tashiro Y
Laboratory of Molecular Cell Biology, Meiji Institute of Health Science, Kanagawa.
J Biochem. 1989 Dec;106(6):1126-31. doi: 10.1093/oxfordjournals.jbchem.a122977.
The biosynthesis of nonspecific lipid transfer protein (nsLTP) was investigated. Total RNA of rat liver was translated in a rabbit reticulocyte lysate cell-free protein-synthesizing system with [35S]methionine as label. The immunoprecipitation of translation products with affinity-purified anti-nsLTP antibody yielded 14.5- and 60-kDa [35S]polypeptides. The molecular mass of the former polypeptide was approximately 1.5 kDa larger than that of the purified mature nsLTP (13 kDa). The site of synthesis of nsLTP was studied by in vitro translation of free and membrane-bound polyribosomal RNAs followed by immunoprecipitation. mRNA for both the 14.5- and 60-kDa polypeptides were found predominantly in the free polyribosomal fraction in both normal and clofibrate-treated rats. Clofibrate, a hypolipidemic drug that proliferates peroxisomes, did not increase the relative amount of nsLTP mRNA in rat liver. Pulse-chase experiments in rat hepatoma H-35 cells suggested that nsLTP was synthesized as a larger precursor of 14.5 kDa and converted to a mature form of 13 kDa. We have recently shown that nsLTP is highly concentrated in peroxisomes in rat hepatocytes [Tsuneoka et al. (1988) J. Biochem. 104, 560-564]. Taken together, these results suggest that nsLTP is synthesized as a larger precursor of 14.5 kDa on cytoplasmic free polyribosomes, then post-translationally transported to peroxisomes, where the precursor is presumably proteolytically processed to its mature form of 13 kDa. The relationship between the 13-kDa nsLTP and the 60-kDa polypeptide is also discussed.
对非特异性脂质转移蛋白(nsLTP)的生物合成进行了研究。以[35S]甲硫氨酸为标记,在兔网织红细胞裂解物无细胞蛋白质合成系统中翻译大鼠肝脏的总RNA。用亲和纯化的抗nsLTP抗体对翻译产物进行免疫沉淀,得到了14.5 kDa和60 kDa的[35S]多肽。前一种多肽的分子量比纯化的成熟nsLTP(13 kDa)大约大1.5 kDa。通过对游离和膜结合多核糖体RNA进行体外翻译,然后进行免疫沉淀,研究了nsLTP的合成位点。在正常和氯贝丁酯处理的大鼠中,14.5 kDa和60 kDa多肽的mRNA主要存在于游离多核糖体部分。氯贝丁酯是一种能使过氧化物酶体增殖的降血脂药物,它并没有增加大鼠肝脏中nsLTP mRNA的相对含量。在大鼠肝癌H-35细胞中进行的脉冲追踪实验表明,nsLTP是以14.5 kDa的较大前体形式合成的,并转化为13 kDa的成熟形式。我们最近发现,nsLTP在大鼠肝细胞的过氧化物酶体中高度浓缩[常冈等人(1988年)《生物化学杂志》104卷,560 - 564页]。综上所述,这些结果表明,nsLTP在细胞质游离多核糖体上以14.5 kDa的较大前体形式合成,然后在翻译后被转运到过氧化物酶体,在那里前体大概被蛋白水解加工成13 kDa的成熟形式。还讨论了13 kDa的nsLTP与60 kDa多肽之间的关系。